Who owns 28176E958 - EDWARDS LIFESCIENCES CORP - COM - Put based on 13F filings?

1 institution reported positions in 28176E958 - EDWARDS LIFESCIENCES CORP - COM - Put as of Q4 2025. Open the latest holders period and ownership history tables on this page for position-level details.

EDWARDS LIFESCIENCES CORP - COM - Put Institutional Ownership

Q: What is CUSIP 28176E958?

CUSIP 28176E958 is the security identifier used in SEC filing datasets for 28176E958 - EDWARDS LIFESCIENCES CORP - COM - Put.

CUSIP: 28176E958

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class: Equity / COM
Price per share: $85.25
All holders as of 31 Dec 2025: Q4 2025
Total 13F shares: 4,800
Total reported value: $409,000
% of total 13F portfolios: 0%
Share change: +4,800
Value change: +$409,000
Number of holders: 1

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 28176E958?
CUSIP 28176E958 identifies 28176E958 - EDWARDS LIFESCIENCES CORP - COM - Put in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 28176E958:

Q4 2025 (1 holder) Q3 2025 (0 holders) Q2 2025 (0 holders) Q1 2025 (0 holders) Q4 2024 (1 holder) Q3 2024 (0 holders) Q2 2024 (0 holders) Q1 2024 (0 holders) Q4 2023 (0 holders) Q3 2023 (0 holders)

As of 31 Dec 2025, 1 institutional investors reported holding 4,800 shares of EDWARDS LIFESCIENCES CORP - COM - Put.

Institutional Holders of EDWARDS LIFESCIENCES CORP - COM - Put across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q4	4,800	$409,000	+$409,000	$48,328,225		$85.25	1
2025 Q3				$28,518,063		$77.77	0
2025 Q2				$38,228,667		$78.21	0
2025 Q1	0	$0	-$465,545	$38,072,920		$72.48	0
2024 Q4	5,040	$465,545	+$465,545	$39,247,042		$74.03	1
2024 Q3				$30,998,254		$65.99	0
2024 Q2				$49,251,751		$92.37	0
2024 Q1				$72,138,188		$95.56	0
2023 Q4				$66,337,125		$76.25	0
2023 Q3				$40,846,776		$69.28	0
2023 Q2				$16,591,992		$94.33	0
2023 Q1				$12,632,352		$82.73	0
2022 Q4				$22,927,310		$74.61	0
2022 Q3				$34,663,000		$82.63	0
2022 Q2				$78,239,000		$95.09	0
2022 Q1				$19,435,000		$117.72	0
2021 Q4				$24,511,000		$129.55	0
2021 Q3				$16,462,000		$113.20	0
2021 Q2				$12,614,000		$103.56	0
2021 Q1				$7,988,000		$83.66	0
2020 Q4				$3,604,000		$91.24	0
2020 Q3				$15,089,000		$79.83	0
2020 Q2				$11,554,000		$69.11	0
2020 Q1				$9,525,000		$188.66	0
2019 Q4	0	$0	-$541,000	$22,512,000		$233.30	0
2019 Q3	2,461	$541,000	+$541,000	$27,247,000		$219.91	1
2019 Q2				$14,155,000		$184.81	0
2019 Q1				$48,655,000		$191.34	0
2018 Q4				$23,051,000		$153.17	0
2018 Q3				$38,111,000		$174.11	0
2018 Q2				$28,182,000		$145.57	0
2018 Q1				$19,216,000		$139.77	0
2017 Q4				$36,514,000		$112.72	0
2017 Q3				$30,661,000		$109.32	0
2017 Q2				$25,323,000		$118.24	0
2017 Q1				$15,123,000		$94.07	0
2016 Q4				$35,544,000		$93.70	0
2016 Q3				$32,249,000		$120.58	0
2016 Q2				$38,877,000	$0	$99.73	0
2016 Q1				$22,957,000	$513,000	$88.21	0
2015 Q4				$17,859,000		$78.96	0
2015 Q3				$45,103,000		$142.22	0
2015 Q2				$31,365,000		$142.44	0
2015 Q1				$8,088,000		$142.45	0
2014 Q4				$10,042,000		$127.40	0
2014 Q3	0	$0	-$27,000	$13,913,000		$102.15	0
2014 Q2	300	$27,000	+$27,000	$7,416,000		$85.84	1
2014 Q1				$6,490,000		$74.17	0